Table 1 Demographic and histopathological details of primary retinoblastoma tumour samples.
From: Clinical relevance of B7H3 expression in retinoblastoma
S.No | Age/Sex | Laterality | Differentiation | Invasion | Risk | Anaplasia | IRS score | Follow up(year)* |
|---|---|---|---|---|---|---|---|---|
RB1 | 2/M | UL | MD | NN | HR | 1 | 12 | 3 |
RB2 | 4/M | UL | MD | N | HR | 2.5 | 9 | 2 |
RB3 | 2/M | UL | PD | N | HR | 2 | 12 | 3 |
RB4 | 4/M | UL | PD | NN | HR | 2 | 9 | 4 |
RB5 | 2/M | UL | PD | NN | LR | 2.5 | 6 | 3 |
RB6 | 3/M | UL | PD | NN | LR | 2 | 9 | 2 |
RB7 | 8/F | UL | PD | NN | HR | 0 | 6 | 4 |
RB8 | 2/M | UL | PD | NIL | LR | 2.5 | 6 | 3 |
RB9 | 3/M | UL | PD | NN | HR | 2 | 4 | 4 |
RB10 | 2/M | UL | MD | N | HR | 3 | 6 | 3 |
RB11 | 0.8/F | UL | MD | NIL | LR | 1 | 6 | 3 |
RB12 | 2/F | UL | WD | NIL | LR | 1 | 2 | 3 |
RB13 | 4/F | UL | PD | NN | LR | 3 | 9 | 4 |
RB14 | 3/F | UL | PD | N | HR | 0 | 12 | 5 |
RB15 | 10/F | UL | WD | NN | HR | 0 | 4 | NA |
RB16 | 6/F | UL | MD | NN | HR | 3 | 9 | 3 |
RB17 | 2/F | UL | PD | NN | HR | 0 | 6 | 2 |
RB18 | 3/M | UL | MD | NN | HR | 2 | 9 | 2 |
RB19 | 2/M | UL | WD | NIL | LR | 0 | 4 | 3 |
RB20 | 5/M | UL | WD | NIL | LR | 0 | 4 | 3 |
RB21 | 2/M | UL | MD | NIL | LR | 3 | 9 | 3 |
RB22 | 4/M | UL | PD | N | HR | 2.5 | 9 | 2 |
RB23 | 2/F | UL | MD | NN | HR | 1 | 6 | 3 |
RB24 | 2/M | UL | MD | N | HR | 3 | 9 | 3 |
RB25 | 3/M | UL | PD | NN | LR | 2 | 9 | 2 |
RB26 | 3/F | BL | PD | NN | HR | 2.5 | 9 | 2 |
RB27 | 2/M | UL | PD | NN | LR | 2 | 6 | 2 |
RB28 | 7/M | UL | PD | NN | HR | 2 | 12 | NA |
RB29 | 2/M | UL | MD | NN | HR | 2 | 6 | 3 |
RB30 | 3/F | UL | PD | NN | HR | 2 | 12 | 3 |
RB31 | 6/M | UL | PD | NN | LR | 0 | 6 | 2 |
RB32 | 3/M | UL | PD | NN | HR | 0 | 6 | 1 |
RB33 | 2/M | UL | MD | NN | HR | 3 | 4 | 3 |
RB34 | 3/F | UL | PD | NN | HR | 2.5 | 12 | 1 |
RB35 | 4/M | UL | PD | NN | LR | 2 | 9 | 1 |